NCT02357290View on ClinicalTrials.gov

Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 24, 2018

Study Completion Date

September 24, 2018

Conditions
Bipolar Disorder
Interventions
DRUG

Open-label Treatment with N-Acetylcysteine

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02357290 - Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders | Biotech Hunter | Biotech Hunter